Molina Healthcare (MOH) CAO Hebert sells 600 shares at $191.55

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Molina Healthcare Chief Accounting Officer Maurice Hebert sold 600 shares of common stock in an open-market transaction at $191.55 per share. After the sale, he directly holds 12,815 shares. Footnotes indicate additional restricted shares are scheduled to vest in 2027, 2028, and 2029, with remaining awards already vested.

Insider Trade Summary

Net Seller: 600 shares ($114,930)

Net Sell 1 txn

Insider HEBERT MAURICE

Role Chief Accounting Officer

Sold 600 shs ($115K)

Type	Security	Shares	Price	Value
Sale	Common Stock	600	$191.55	$115K

Holdings After Transaction: Common Stock — 12,815 shares (Direct, null)

Footnotes (1)

Represents the selling price per share of all 600 shares. The shares vest as follows: 1,245 shares on March 1, 2027; 986 shares on March 1, 2028, and 686 shares on March 1, 2029. The remaining shares are vested.

Key Figures

Shares sold: 600 shares Sale price: $191.55 per share Shares held after sale: 12,815 shares +3 more

6 metrics

Shares sold 600 shares Open-market sale by CAO Maurice Hebert

Sale price $191.55 per share Price applied to all 600 shares sold

Shares held after sale 12,815 shares Direct holdings following the transaction

RSUs vesting 2027 1,245 shares Scheduled vesting on March 1, 2027

RSUs vesting 2028 986 shares Scheduled vesting on March 1, 2028

RSUs vesting 2029 686 shares Scheduled vesting on March 1, 2029

Key Terms

open-market sale, Chief Accounting Officer, vest, Form 4

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Chief Accounting Officer financial

"officer_title": "Chief Accounting Officer""

A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

vest financial

"The shares vest as follows: 1,245 shares on March 1, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/15/2026 - 04:35 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HEBERT MAURICE

(Last)

(First)

(Middle)

200 OCEANGATE, SUITE 100

(Street)

LONG BEACH

CALIFORNIA

90802

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/14/2026		S		600	D	$191.55⁽¹⁾	12,815⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the selling price per share of all 600 shares.

2. The shares vest as follows: 1,245 shares on March 1, 2027; 986 shares on March 1, 2028, and 686 shares on March 1, 2029. The remaining shares are vested.

Remarks:

	Jeff D. Barlow, by power of attorney for Maurice Hebert	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Molina Healthcare (MOH) report for Maurice Hebert?

Molina Healthcare reported that Chief Accounting Officer Maurice Hebert sold 600 shares of common stock in an open-market transaction at $191.55 per share. This Form 4 filing shows a routine disposition of a relatively small portion of his overall equity stake.

How many Molina Healthcare (MOH) shares does Maurice Hebert hold after this sale?

After selling 600 shares, Maurice Hebert directly holds 12,815 shares of Molina Healthcare common stock. This post-transaction balance is disclosed in the Form 4 and indicates he retains a significant remaining equity position in the company following the reported sale.

At what price were Maurice Hebert’s Molina Healthcare (MOH) shares sold?

The 600 Molina Healthcare shares reported in the Form 4 were sold at $191.55 per share. A footnote clarifies that this price represents the selling price per share for the entire 600-share block disclosed in the transaction.

What is Maurice Hebert’s role at Molina Healthcare (MOH) in this Form 4?

In this Form 4 filing, Maurice Hebert is identified as an officer of Molina Healthcare, serving as Chief Accounting Officer. The reported transaction reflects his personal trading activity in the company’s common stock as an executive-level insider.

Does the Form 4 show any unvested Molina Healthcare (MOH) equity awards for Maurice Hebert?

Yes. A footnote states that 1,245 shares vest on March 1, 2027, 986 shares on March 1, 2028, and 686 shares on March 1, 2029. It also notes that all remaining shares from these awards are already vested as of the filing.